AU4329396A - Use of 3,4-diphenylchromans - Google Patents

Use of 3,4-diphenylchromans

Info

Publication number
AU4329396A
AU4329396A AU43293/96A AU4329396A AU4329396A AU 4329396 A AU4329396 A AU 4329396A AU 43293/96 A AU43293/96 A AU 43293/96A AU 4329396 A AU4329396 A AU 4329396A AU 4329396 A AU4329396 A AU 4329396A
Authority
AU
Australia
Prior art keywords
diphenylchromans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU43293/96A
Other versions
AU693628B2 (en
Inventor
Martin William Edwards
Birgitte Hjort Guldhammer
Ved Prakash Kamboj
Niels Korsgaard
Virender Mohan Labroo
James Robertson Piggott
Suprabhat Ray
Michael Shalmi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU4329396A publication Critical patent/AU4329396A/en
Application granted granted Critical
Publication of AU693628B2 publication Critical patent/AU693628B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
AU43293/96A 1995-01-13 1996-01-10 Use of 3,4-diphenylchromans Ceased AU693628B2 (en)

Applications Claiming Priority (21)

Application Number Priority Date Filing Date Title
DK47/95 1995-01-13
DK45/95 1995-01-13
DK46/95 1995-01-13
DK4495 1995-01-13
DK4895 1995-01-13
DK4795 1995-01-13
DK4695 1995-01-13
DK4595 1995-01-13
DK48/95 1995-01-13
DK44/95 1995-01-13
DK772/95 1995-06-30
DK77195 1995-06-30
DK769/95 1995-06-30
DK768/95 1995-06-30
DK771/95 1995-06-30
DK77295 1995-06-30
DK76995 1995-06-30
DK77095 1995-06-30
DK76895 1995-06-30
DK770/95 1995-06-30
PCT/DK1996/000015 WO1996021444A1 (en) 1995-01-13 1996-01-10 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of gynaecological disorders

Publications (2)

Publication Number Publication Date
AU4329396A true AU4329396A (en) 1996-07-31
AU693628B2 AU693628B2 (en) 1998-07-02

Family

ID=27579214

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43293/96A Ceased AU693628B2 (en) 1995-01-13 1996-01-10 Use of 3,4-diphenylchromans

Country Status (11)

Country Link
EP (1) EP0804190A1 (en)
JP (1) JPH10511962A (en)
CN (1) CN1168096A (en)
AU (1) AU693628B2 (en)
CA (1) CA2208861A1 (en)
CZ (1) CZ212297A3 (en)
HU (1) HUP9702244A3 (en)
IL (1) IL116746A0 (en)
MX (1) MX9705219A (en)
NO (1) NO973243D0 (en)
WO (1) WO1996021444A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0937061A1 (en) * 1996-10-28 1999-08-25 Novo Nordisk A/S NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
DK0937062T3 (en) * 1996-10-28 2003-04-07 Novo Nordisk As New cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen-related diseases or syndromes
ZA979644B (en) * 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
AU4699897A (en) * 1996-10-28 1998-05-22 Novo Nordisk A/S Novel (-)-enantiomers of (cis)-3,4-chroman derivatives useful in the preve ntion or treatment of estrogen related diseases or syndromes
US6043269A (en) * 1996-10-28 2000-03-28 Novo Nordisk A/S cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5919817A (en) * 1996-10-28 1999-07-06 Novo Nordisk A/S Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5994390A (en) * 1996-10-28 1999-11-30 Novo Nordisk Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA979646B (en) * 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
AU4772297A (en) * 1996-10-28 1998-05-22 Novo Nordisk A/S Novel (cis)-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
AU4772097A (en) * 1996-10-28 1998-05-22 Novo Nordisk A/S Novel (cis)-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5985306A (en) * 1996-10-28 1999-11-16 Novo Nordisk A/S (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
CA2270113A1 (en) * 1996-10-28 1998-05-07 Poul Jacobsen Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US5958967A (en) * 1996-10-28 1999-09-28 Novo Nordisk A/S Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US6316494B1 (en) 1996-10-28 2001-11-13 Novo Nordisk A/S cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA979643B (en) * 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
JP4896335B2 (en) 2000-03-01 2012-03-14 ナームローゼ・フエンノートチヤツプ・オルガノン Chroman derivatives as estrogen compounds
US7601855B2 (en) 2004-09-21 2009-10-13 Novogen Research Pty Ltd Substituted chroman derivatives, medicaments and use in therapy
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
EP2635273B1 (en) 2010-11-01 2020-01-08 MEI Pharma, Inc. Isoflavonoid compositions and methods for the treatment of cancer
ES2643407T3 (en) 2014-02-07 2017-11-22 Novogen Ltd. Functionalized benzopyran compounds and their use
AU2016215515B2 (en) 2015-02-02 2020-04-30 Mei Pharma, Inc. Combination therapies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

Also Published As

Publication number Publication date
EP0804190A1 (en) 1997-11-05
HUP9877967A2 (en) 1998-12-28
HUP9702244A3 (en) 1999-12-28
IL116746A0 (en) 1996-05-14
NO973243L (en) 1997-07-11
CZ212297A3 (en) 1997-11-12
MX9705219A (en) 1997-10-31
AU693628B2 (en) 1998-07-02
WO1996021444A1 (en) 1996-07-18
CA2208861A1 (en) 1996-07-18
NO973243D0 (en) 1997-07-11
CN1168096A (en) 1997-12-17
JPH10511962A (en) 1998-11-17

Similar Documents

Publication Publication Date Title
AU5235796A (en) o-hydroxyphenyl-s-triazines
AU4780896A (en) Core-board
AU6000496A (en) Phenylpyridazinones
AU5896396A (en) Pyridine-microbicides
AU1030997A (en) Taphane
AU4329396A (en) Use of 3,4-diphenylchromans
PL324992A1 (en) Novel derivatives of 2,3-dioxotetrahydoquinoxaline
AU3284395A (en) Synthesis of 1,1,1,3,3,-pentafluoropropane
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AU6123196A (en) N-aryl-1,2,4-triazolin-5-ones
AU5147496A (en) Fucopeptides
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU5593896A (en) Benzisothiazolyl-substituted aminomethylchromans
AU6235496A (en) Azothiophenes
AU5500196A (en) Anti-transpirants
AU4382896A (en) Acetylimidazobenzodiazepines
AU4361696A (en) New uses of indolo-{2,3b}-quinoxalines
AU5108596A (en) Morphine-3-esters
AU6215196A (en) Piperidinylmethyloxazolidinones
AU5917896A (en) Poly-beta-1-4-N-acetylglucosamine
AU5013796A (en) Wireclamp
AU5107096A (en) Haemodialyser
AU4569496A (en) Tetralinyl- and indanyl-ethylamides
AU6658396A (en) Polyhydroxyalkylamidobetaine
AU6124596A (en) Mercapto-bis-triazoles

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired